טוען...
Compassionate use of orphan drugs
BACKGROUND: EU regulation 726/2004 authorises manufacturers to provide drugs to patients on a temporary basis when marketing authorisation sought centrally for the entire EU is still pending. Individual Member States retain the right to approve and implement such ‘compassionate use’ programmes which...
שמור ב:
| הוצא לאור ב: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546220/ https://ncbi.nlm.nih.gov/pubmed/26292942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-015-0306-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|